Latest filings (excl ownership)
No filings
Latest ownership filings
4
CAVA GROUP, INC.
28 Aug 24
144
CAVA GROUP, INC.
26 Aug 24
13F-NT
Notice of holdings reported by another manager
14 Aug 24
SC 13G/A
Korro Bio, Inc.
12 Jul 24
SC 13G/A
Cyclerion Therapeutics, Inc.
12 Jul 24
SC 13G/A
Cartesian Therapeutics, Inc.
12 Jul 24
SC 13G
HOOKIPA Pharma Inc.
8 Jul 24
4
CAVA GROUP, INC.
7 Jun 24
144
CAVA GROUP, INC.
5 Jun 24
4
LEXICON PHARMACEUTICALS, INC.
14 May 24
13F-NT
Notice of holdings reported by another manager
13 May 24
SC 13G/A
Achilles Therapeutics plc
29 Mar 24
SC 13G/A
Vigil Neuroscience, Inc.
29 Mar 24
4
CAVA GROUP, INC.
25 Mar 24
144
CAVA GROUP, INC.
21 Mar 24
4
LEXICON PHARMACEUTICALS, INC.
13 Mar 24
4
CAVA GROUP, INC.
29 Feb 24
144
CAVA GROUP, INC.
27 Feb 24
SC 13G/A
Aptinyx Inc.
9 Feb 24
SC 13G/A
Aravive, Inc.
9 Feb 24
SC 13G/A
Scholar Rock Holding Corp
9 Feb 24
SC 13G/A
Cartesian Therapeutics, Inc.
9 Feb 24
SC 13G/A
Vigil Neuroscience, Inc.
9 Feb 24
SC 13G/A
Allovir, Inc.
9 Feb 24
SC 13G/A
IGM Biosciences, Inc.
9 Feb 24
SC 13G/A
AGENUS INC
9 Feb 24
SC 13G/A
SQZ Biotechnologies Co
9 Feb 24
SC 13G/A
Harpoon Therapeutics, Inc.
9 Feb 24
SC 13G/A
Syros Pharmaceuticals, Inc.
9 Feb 24
SC 13G/A
Ambrx Biopharma Cayman, Inc.
9 Feb 24
SC 13G/A
Nanobiotix S.A.
9 Feb 24
SC 13G/A
Morphic Holding, Inc.
9 Feb 24
SC 13G/A
Cyclerion Therapeutics, Inc.
9 Feb 24
SC 13G/A
Silence Therapeutics plc
9 Feb 24
SC 13G
CAVA GROUP, INC.
9 Feb 24
SC 13G/A
GLYCOMIMETICS INC
9 Feb 24
13F-NT
Notice of holdings reported by another manager
9 Feb 24
SC 13G
Solid Biosciences Inc.
22 Jan 24
SC 13G
Gossamer Bio, Inc.
11 Jan 24
SC 13G
Korro Bio, Inc.
13 Nov 23